FDA Panel Wants Tighter Control over Pain Pills
It may soon be harder for patients to get access to hydrocodone-based pain relievers like Vicodin after an FDA advisory panel recommended moving them from Schedule III to Schedule II in an effort to prevent overdoses and addiction.